- Yale Therapeutic RadiologySmilow Cancer Hospital Care Center - Waterford230 Waterford Parkway SouthWaterford, CT 06385
Meena S. Moran, MD
Biography
As the director of the Yale Medicine Breast Radiotherapy Program and professor of Therapeutic Radiology at Yale University School of Medicine, Meena Moran, MD, is committed to not only helping her own patients but all breast cancer patients. “My passion lies with providing patients with individualized care, along with improving the standard of care in the field of breast cancer management as a whole,” says Dr. Moran.
An internationally known expert, she is frequently invited to lecture worldwide, educating physicians about state-of-the-art breast cancer treatment. In addition, she has served on numerous panels to develop guidelines and standards for breast health care. She is a panel member for the National Comprehensive Cancer Network and a founding board member of the National Accreditation Program for Breast Centers. She has published numerous book chapters and journal articles pertaining to her research on radiation techniques, predictors of relapse, and ethnic variations in breast cancer.
In her work as a Yale Medicine doctor, she has standardized breast cancer radiotherapy treatment throughout all of Smilow Cancer Hospital Care Centers. As a result, breast cancer patients can be certain they are receiving the same level of treatment. “All of our breast cancer cases across all our sites are presented and reviewed weekly at our breast team meeting,” says Dr. Moran, “and this is an important initiative so that patients can be assured of getting the best care, regardless of which treatment facility they go to.”
Because breast radiation is not only a local treatment modality, but also has long-term effects on improving survival in general, the radiation a breast cancer patient receives is a critical part of treatment, says Dr. Moran. “I am confident that with our integrated breast program across our all our sites, our Yale Medicine breast radiation doctors are delivering the highest level of care available to all of our breast cancer patients."
Titles
- Professor of Therapeutic Radiology
- Medical Director, Smilow Cancer Hospital Care Center in Waterford
- Chief, Breast Radiation Oncology
Education & Training
- ResidentYale-New Haven Hospital (1998)
- InternRoosevelt Hospital, Columbia University (1995)
- MDCornell University Medical College (1994)
Languages Spoken
- English
- मराठी (Marathi)
Additional Information
- American College of Radiology (2009 - Present): Breast Expert Panel-Radiation Oncology, Appropriateness Criteria Committee
- (2009 - 2012): Chair, American Society of Therapeutic Radiation Oncology, Breast Abstract Panel/Scientific Sub-Committee
- Member (2009 - Present): 3rd Annual American Society of Clinical Oncology Breast Symposium,
- (2008 - 2012): Member, Information Technology and Outcome/ National Breast Cancer Database Committee
- Member (2008 - 2012): Information Technology Committee
- (2008 - 2012): Member, Breast Abstract Review Committee, 50th Annual American Society of Therapeutic Radiology and Oncology,
- (2008 - 2011): Chair, American Radium Society Nomination Committee, 2008-2011
- American Radium Society (ARS) (2008 - 2010): Moderator, faculty, discussant, committees
- (2008): Chair, ASCO Breast Symposium, Radiation Therapy Section III
- (2008 - Present): Member, Program Committee, 2nd Annual American Society of Clinical Oncology Breast Symposium,
- Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2016, 34: 4040-4046. PMID: 27528719, PMCID: PMC5477830, DOI: 10.1200/JCO.2016.68.3573.
- Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, Klimberg S, Chavez-MacGregor M, Freedman G, Houssami N, Johnson PL, Morrow M. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Annals Of Surgical Oncology 2014, 21: 704-16. PMID: 24515565, DOI: 10.1245/s10434-014-3481-4.
- Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis CA, Isakoff SJ, Marcom PK, Mayer IA, McCormick B, Moran M, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network : JNCCN 2016, 14: 324-54. PMID: 26957618, DOI: 10.6004/jnccn.2016.0037.
- Ding X, Yang Q, Kong X, Haffty BG, Gao S, Moran MS. Radiosensitization effect of Huaier on breast cancer cells. Oncology Reports 2016, 35: 2843-50. PMID: 26935024, DOI: 10.3892/or.2016.4630.
- DeSnyder SM, Hunt KK, Smith BD, Moran MS, Klimberg S, Lucci A. Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer. Annals Of Surgical Oncology 2015, 22: 3250-6. PMID: 26202554, PMCID: PMC4696114, DOI: 10.1245/s10434-015-4666-1.
- Schnitt SJ, Moran MS, Houssami N, Morrow M. The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. Archives Of Pathology & Laboratory Medicine 2015, 139: 575-7. PMID: 25153620, DOI: 10.5858/arpa.2014-0384-ED.
- Wobb JL, Chen PY, Shah C, Moran MS, Shaitelman SF, Vicini FA, Mbah AK, Lyden M, Beitsch P. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. International Journal Of Radiation Oncology, Biology, Physics 2015, 91: 312-8. PMID: 25446607, DOI: 10.1016/j.ijrobp.2014.09.029.
- Moran MS, Gonsalves L, Goss DM, Ma S. Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival. Breast Cancer Research And Treatment 2011, 128: 543-51. PMID: 21301957, PMCID: PMC3235412, DOI: 10.1007/s10549-011-1362-0.
- Moran MS, Yang Q, Harris LN, Jones B, Tuck DP, Haffty BG. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer. Cancer 2008, 113: 2565-74. PMID: 18816610, DOI: 10.1002/cncr.23881.
- Yang Q, Moran MS, Haffty BG. Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy. Breast Cancer Research And Treatment 2009, 115: 343-8. PMID: 18516673, DOI: 10.1007/s10549-008-0068-4.
- Liu GF, Yang Q, Haffty BG, Moran MS. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. International Journal Of Radiation Oncology, Biology, Physics 2009, 75: 1304-8. PMID: 19386432, DOI: 10.1016/j.ijrobp.2008.12.070.
- Goyal S, Parikh RR, Green C, Schiff D, Moran MS, Yang Q, Haffty BG. Clinicopathologic significance of excision repair cross-complementation 1 expression in patients treated with breast-conserving surgery and radiation therapy. International Journal Of Radiation Oncology, Biology, Physics 2010, 76: 679-84. PMID: 19464815, DOI: 10.1016/j.ijrobp.2009.02.050.
- Haffty BG, Choi DH, Goyal S, Silber A, Ranieri K, Matloff E, Lee MH, Nissenblatt M, Toppmeyer D, Moran MS. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / ESMO 2009, 20: 1653-9. PMID: 19491284, DOI: 10.1093/annonc/mdp051.
- Moran MS, Haffty BG. Radiation techniques and toxicities for locally advanced breast cancer. Seminars In Radiation Oncology 2009, 19: 244-55. PMID: 19732689, DOI: 10.1016/j.semradonc.2009.05.007.
- Moran MS, Yang Q, Haffty BG. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology. The Breast Journal 2009, 15: 571-8. PMID: 19995377, DOI: 10.1111/j.1524-4741.2009.00833.x.
- Ma S, Huang J, Moran MS. Identification of genes associated with multiple cancers via integrative analysis. BMC Genomics 2009, 10: 535. PMID: 19919702, PMCID: PMC2785840, DOI: 10.1186/1471-2164-10-535.
- Sharma C, Harris L, Haffty BG, Yang Q, Moran MS. Does compliance with radiation therapy differ in African-American patients with early-stage breast cancer? The Breast Journal 2010, 16: 193-6. PMID: 20030649, DOI: 10.1111/j.1524-4741.2009.00874.x.
- Parikh RR, Haffty BG, Lannin D, Moran MS. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. International Journal Of Radiation Oncology, Biology, Physics 2012, 82: 7-13. PMID: 20950955, DOI: 10.1016/j.ijrobp.2010.08.027.
- Moran MS, Yang Q, Goyal S, Harris L, Chung G, Haffty BG. Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy. International Journal Of Radiation Oncology, Biology, Physics 2011, 81: 1236-43. PMID: 21093162, DOI: 10.1016/j.ijrobp.2010.07.031.
- Bellon JR, Harris EE, Arthur DW, Bailey L, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, MacDonald SM, Haffty BG. ACR Appropriateness Criteria® conservative surgery and radiation--stage I and II breast carcinoma: expert panel on radiation oncology: breast. The Breast Journal 2011, 17: 448-55. PMID: 21790842, DOI: 10.1111/j.1524-4741.2011.01132.x.
- Zhang X, Li X, Zhang N, Yang Q, Moran MS. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial-mesenchymal transition. Biochemical And Biophysical Research Communications 2011, 412: 188-92. PMID: 21810413, DOI: 10.1016/j.bbrc.2011.07.074.
- Macdonald SM, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, Haffty BG. ACR appropriateness criteria® locally advanced breast cancer. The Breast Journal 2011, 17: 579-85. PMID: 21906206, DOI: 10.1111/j.1524-4741.2011.01150.x.
- Moran MS, Knobf MT. Raising the bar for breast health care in the United States. Women's Health Issues : Official Publication Of The Jacobs Institute Of Women's Health 2012, 22: e129-33. PMID: 22037415, DOI: 10.1016/j.whi.2011.08.011.
- Castrucci W, Lannin D, Haffty BG, Higgins SA, Moran MS. Using nodal ratios to predict risk of regional recurrences in patients treated with breast conservation therapy with 4 or more positive lymph nodes. ISRN Surgery 2011, 2011: 874814. PMID: 22084784, PMCID: PMC3200302, DOI: 10.5402/2011/874814.
- Moran MS, Bai HX, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, MacDonald SM, Haffty BG. ACR appropriateness criteria(®) ductal carcinoma in situ. The Breast Journal 2012, 18: 8-15. PMID: 22107336, DOI: 10.1111/j.1524-4741.2011.01197.x.
- Moran MS, Ma S, Jagsi R, Yang TJ, Higgins SA, Weidhaas JB, Wilson LD, Lloyd S, Peschel R, Gaudreau B, Rockwell S. A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer. International Journal Of Radiation Oncology, Biology, Physics 2013, 85: 40-6. PMID: 22658441, DOI: 10.1016/j.ijrobp.2012.03.025.
- Nelson C, Bai H, Neboori H, Takita C, Motwani S, Wright JL, Hobeika G, Haffty BG, Jones T, Goyal S, Moran MS. Multi-institutional experience of ductal carcinoma in situ in black vs white patients treated with breast-conserving surgery and whole breast radiation therapy. International Journal Of Radiation Oncology, Biology, Physics 2012, 84: e279-83. PMID: 22672752, DOI: 10.1016/j.ijrobp.2012.03.068.
- Evans SB, Panigrahi B, Northrup V, Patterson J, Baldwin DE, Higgins SA, Moran MS. Analysis of coronary artery dosimetry in the 3-dimensional era: Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation. Practical Radiation Oncology 2013, 3: e55-60. PMID: 24674321, DOI: 10.1016/j.prro.2012.06.007.
- Halyard MY, Harris EE, Bailey L, Bellon JR, Freedman GM, Goyal S, Horst KC, Moran MS, Park CC, Suh WW, Toppmeyer D, Haffty BG. ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer. Oncology (Williston Park, N.Y.) 2014, 28: 157-64, C3. PMID: 24701707.
- Moran MS. Should triple-negative breast cancer (TNBC) subtype affect local-regional therapy decision making? American Society Of Clinical Oncology Educational Book / ASCO. American Society Of Clinical Oncology. Meeting 2014, e32-6. PMID: 24857120, DOI: 10.14694/EdBook_AM.2014.34.e32.
- Jones T, Neboori H, Wu H, Yang Q, Haffty BG, Evans S, Higgins S, Moran MS. Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer? Annals Of Surgical Oncology 2013, 20: 2866-72. PMID: 23661183, PMCID: PMC5731457, DOI: 10.1245/s10434-013-2994-6.
- Bai HX, Motwani SB, Higgins SA, Haffty BG, Wilson LD, Lannin DR, Evans SB, Moran MS. Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes? International Journal Of Clinical Oncology 2014, 19: 460-6. PMID: 23780727, DOI: 10.1007/s10147-013-0575-0.
- Khan AJ, Parikh RR, Neboori HJ, Goyal S, Haffty BG, Moran MS. The relative benefits of tamoxifen in older women with T1 early-stage breast cancer treated with breast-conserving surgery and radiation therapy. The Breast Journal 2013, 19: 490-5. PMID: 23800027, DOI: 10.1111/tbj.12150.
- Moran MS, Kaufman C, Burgin C, Swain S, Granville T, Winchester DP. What currently defines a breast center? Initial data from the national accreditation program for breast centers. Journal Of Oncology Practice / American Society Of Clinical Oncology 2013, 9: e62-70. PMID: 23814526, PMCID: PMC3595452, DOI: 10.1200/JOP.2012.000636.
- Hafeez F, Neboori HJ, Harigopal M, Wu H, Haffty BG, Yang Q, Schiff D, Moran MS. Is Ki-67 expression prognostic for local relapse in early-stage breast cancer patients treated with breast conservation therapy (BCT)? International Journal Of Radiation Oncology, Biology, Physics 2013, 87: 344-8. PMID: 23910708, DOI: 10.1016/j.ijrobp.2013.05.052.
- Moran MS, Goss D, Haffty BG, Kaufman CS, Winchester DP. Quality measures, standards, and accreditation for breast centers in the United States. International Journal Of Radiation Oncology, Biology, Physics 2010, 76: 1-4. PMID: 20005450, DOI: 10.1016/j.ijrobp.2009.08.010.
- Moran MS. Should low-risk patients be treated with three-dimensional conformal radiation therapy-accelerated partial-breast irradiation in an off-protocol setting? Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2013, 31: 4032-7. PMID: 24081936, DOI: 10.1200/JCO.2013.51.1642.
- Moran MS, Truong PT. Intraoperative accelerated partial breast irradiation: caution still warranted. International Journal Of Radiation Oncology, Biology, Physics 2014, 89: 496-8. PMID: 24929161, DOI: 10.1016/j.ijrobp.2014.01.034.
- Truong PT, Smith SL, Moran MS. Perspectives in breast cancer treatment: APBI and breast-conserving surgery. In reply to Morgan and Vaidya. International Journal Of Radiation Oncology, Biology, Physics 2014, 90: 967-8. PMID: 25585789, DOI: 10.1016/j.ijrobp.2014.07.047.
- Moran MS. Radiation therapy in the locoregional treatment of triple-negative breast cancer. The Lancet. Oncology 2015, 16: e113-22. PMID: 25752562, DOI: 10.1016/S1470-2045(14)71104-0.
Biography
As the director of the Yale Medicine Breast Radiotherapy Program and professor of Therapeutic Radiology at Yale University School of Medicine, Meena Moran, MD, is committed to not only helping her own patients but all breast cancer patients. “My passion lies with providing patients with individualized care, along with improving the standard of care in the field of breast cancer management as a whole,” says Dr. Moran.
An internationally known expert, she is frequently invited to lecture worldwide, educating physicians about state-of-the-art breast cancer treatment. In addition, she has served on numerous panels to develop guidelines and standards for breast health care. She is a panel member for the National Comprehensive Cancer Network and a founding board member of the National Accreditation Program for Breast Centers. She has published numerous book chapters and journal articles pertaining to her research on radiation techniques, predictors of relapse, and ethnic variations in breast cancer.
In her work as a Yale Medicine doctor, she has standardized breast cancer radiotherapy treatment throughout all of Smilow Cancer Hospital Care Centers. As a result, breast cancer patients can be certain they are receiving the same level of treatment. “All of our breast cancer cases across all our sites are presented and reviewed weekly at our breast team meeting,” says Dr. Moran, “and this is an important initiative so that patients can be assured of getting the best care, regardless of which treatment facility they go to.”
Because breast radiation is not only a local treatment modality, but also has long-term effects on improving survival in general, the radiation a breast cancer patient receives is a critical part of treatment, says Dr. Moran. “I am confident that with our integrated breast program across our all our sites, our Yale Medicine breast radiation doctors are delivering the highest level of care available to all of our breast cancer patients."
Titles
- Professor of Therapeutic Radiology
- Medical Director, Smilow Cancer Hospital Care Center in Waterford
- Chief, Breast Radiation Oncology
Education & Training
- ResidentYale-New Haven Hospital (1998)
- InternRoosevelt Hospital, Columbia University (1995)
- MDCornell University Medical College (1994)
Languages Spoken
- English
- मराठी (Marathi)
Additional Information
- American College of Radiology (2009 - Present): Breast Expert Panel-Radiation Oncology, Appropriateness Criteria Committee
- (2009 - 2012): Chair, American Society of Therapeutic Radiation Oncology, Breast Abstract Panel/Scientific Sub-Committee
- Member (2009 - Present): 3rd Annual American Society of Clinical Oncology Breast Symposium,
- (2008 - 2012): Member, Information Technology and Outcome/ National Breast Cancer Database Committee
- Member (2008 - 2012): Information Technology Committee
- (2008 - 2012): Member, Breast Abstract Review Committee, 50th Annual American Society of Therapeutic Radiology and Oncology,
- (2008 - 2011): Chair, American Radium Society Nomination Committee, 2008-2011
- American Radium Society (ARS) (2008 - 2010): Moderator, faculty, discussant, committees
- (2008): Chair, ASCO Breast Symposium, Radiation Therapy Section III
- (2008 - Present): Member, Program Committee, 2nd Annual American Society of Clinical Oncology Breast Symposium,
- Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2016, 34: 4040-4046. PMID: 27528719, PMCID: PMC5477830, DOI: 10.1200/JCO.2016.68.3573.
- Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, Klimberg S, Chavez-MacGregor M, Freedman G, Houssami N, Johnson PL, Morrow M. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Annals Of Surgical Oncology 2014, 21: 704-16. PMID: 24515565, DOI: 10.1245/s10434-014-3481-4.
- Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis CA, Isakoff SJ, Marcom PK, Mayer IA, McCormick B, Moran M, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network : JNCCN 2016, 14: 324-54. PMID: 26957618, DOI: 10.6004/jnccn.2016.0037.
- Ding X, Yang Q, Kong X, Haffty BG, Gao S, Moran MS. Radiosensitization effect of Huaier on breast cancer cells. Oncology Reports 2016, 35: 2843-50. PMID: 26935024, DOI: 10.3892/or.2016.4630.
- DeSnyder SM, Hunt KK, Smith BD, Moran MS, Klimberg S, Lucci A. Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer. Annals Of Surgical Oncology 2015, 22: 3250-6. PMID: 26202554, PMCID: PMC4696114, DOI: 10.1245/s10434-015-4666-1.
- Schnitt SJ, Moran MS, Houssami N, Morrow M. The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. Archives Of Pathology & Laboratory Medicine 2015, 139: 575-7. PMID: 25153620, DOI: 10.5858/arpa.2014-0384-ED.
- Wobb JL, Chen PY, Shah C, Moran MS, Shaitelman SF, Vicini FA, Mbah AK, Lyden M, Beitsch P. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. International Journal Of Radiation Oncology, Biology, Physics 2015, 91: 312-8. PMID: 25446607, DOI: 10.1016/j.ijrobp.2014.09.029.
- Moran MS, Gonsalves L, Goss DM, Ma S. Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival. Breast Cancer Research And Treatment 2011, 128: 543-51. PMID: 21301957, PMCID: PMC3235412, DOI: 10.1007/s10549-011-1362-0.
- Moran MS, Yang Q, Harris LN, Jones B, Tuck DP, Haffty BG. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer. Cancer 2008, 113: 2565-74. PMID: 18816610, DOI: 10.1002/cncr.23881.
- Yang Q, Moran MS, Haffty BG. Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy. Breast Cancer Research And Treatment 2009, 115: 343-8. PMID: 18516673, DOI: 10.1007/s10549-008-0068-4.
- Liu GF, Yang Q, Haffty BG, Moran MS. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. International Journal Of Radiation Oncology, Biology, Physics 2009, 75: 1304-8. PMID: 19386432, DOI: 10.1016/j.ijrobp.2008.12.070.
- Goyal S, Parikh RR, Green C, Schiff D, Moran MS, Yang Q, Haffty BG. Clinicopathologic significance of excision repair cross-complementation 1 expression in patients treated with breast-conserving surgery and radiation therapy. International Journal Of Radiation Oncology, Biology, Physics 2010, 76: 679-84. PMID: 19464815, DOI: 10.1016/j.ijrobp.2009.02.050.
- Haffty BG, Choi DH, Goyal S, Silber A, Ranieri K, Matloff E, Lee MH, Nissenblatt M, Toppmeyer D, Moran MS. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / ESMO 2009, 20: 1653-9. PMID: 19491284, DOI: 10.1093/annonc/mdp051.
- Moran MS, Haffty BG. Radiation techniques and toxicities for locally advanced breast cancer. Seminars In Radiation Oncology 2009, 19: 244-55. PMID: 19732689, DOI: 10.1016/j.semradonc.2009.05.007.
- Moran MS, Yang Q, Haffty BG. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology. The Breast Journal 2009, 15: 571-8. PMID: 19995377, DOI: 10.1111/j.1524-4741.2009.00833.x.
- Ma S, Huang J, Moran MS. Identification of genes associated with multiple cancers via integrative analysis. BMC Genomics 2009, 10: 535. PMID: 19919702, PMCID: PMC2785840, DOI: 10.1186/1471-2164-10-535.
- Sharma C, Harris L, Haffty BG, Yang Q, Moran MS. Does compliance with radiation therapy differ in African-American patients with early-stage breast cancer? The Breast Journal 2010, 16: 193-6. PMID: 20030649, DOI: 10.1111/j.1524-4741.2009.00874.x.
- Parikh RR, Haffty BG, Lannin D, Moran MS. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. International Journal Of Radiation Oncology, Biology, Physics 2012, 82: 7-13. PMID: 20950955, DOI: 10.1016/j.ijrobp.2010.08.027.
- Moran MS, Yang Q, Goyal S, Harris L, Chung G, Haffty BG. Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy. International Journal Of Radiation Oncology, Biology, Physics 2011, 81: 1236-43. PMID: 21093162, DOI: 10.1016/j.ijrobp.2010.07.031.
- Bellon JR, Harris EE, Arthur DW, Bailey L, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, MacDonald SM, Haffty BG. ACR Appropriateness Criteria® conservative surgery and radiation--stage I and II breast carcinoma: expert panel on radiation oncology: breast. The Breast Journal 2011, 17: 448-55. PMID: 21790842, DOI: 10.1111/j.1524-4741.2011.01132.x.
- Zhang X, Li X, Zhang N, Yang Q, Moran MS. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial-mesenchymal transition. Biochemical And Biophysical Research Communications 2011, 412: 188-92. PMID: 21810413, DOI: 10.1016/j.bbrc.2011.07.074.
- Macdonald SM, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, Haffty BG. ACR appropriateness criteria® locally advanced breast cancer. The Breast Journal 2011, 17: 579-85. PMID: 21906206, DOI: 10.1111/j.1524-4741.2011.01150.x.
- Moran MS, Knobf MT. Raising the bar for breast health care in the United States. Women's Health Issues : Official Publication Of The Jacobs Institute Of Women's Health 2012, 22: e129-33. PMID: 22037415, DOI: 10.1016/j.whi.2011.08.011.
- Castrucci W, Lannin D, Haffty BG, Higgins SA, Moran MS. Using nodal ratios to predict risk of regional recurrences in patients treated with breast conservation therapy with 4 or more positive lymph nodes. ISRN Surgery 2011, 2011: 874814. PMID: 22084784, PMCID: PMC3200302, DOI: 10.5402/2011/874814.
- Moran MS, Bai HX, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, MacDonald SM, Haffty BG. ACR appropriateness criteria(®) ductal carcinoma in situ. The Breast Journal 2012, 18: 8-15. PMID: 22107336, DOI: 10.1111/j.1524-4741.2011.01197.x.
- Moran MS, Ma S, Jagsi R, Yang TJ, Higgins SA, Weidhaas JB, Wilson LD, Lloyd S, Peschel R, Gaudreau B, Rockwell S. A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer. International Journal Of Radiation Oncology, Biology, Physics 2013, 85: 40-6. PMID: 22658441, DOI: 10.1016/j.ijrobp.2012.03.025.
- Nelson C, Bai H, Neboori H, Takita C, Motwani S, Wright JL, Hobeika G, Haffty BG, Jones T, Goyal S, Moran MS. Multi-institutional experience of ductal carcinoma in situ in black vs white patients treated with breast-conserving surgery and whole breast radiation therapy. International Journal Of Radiation Oncology, Biology, Physics 2012, 84: e279-83. PMID: 22672752, DOI: 10.1016/j.ijrobp.2012.03.068.
- Evans SB, Panigrahi B, Northrup V, Patterson J, Baldwin DE, Higgins SA, Moran MS. Analysis of coronary artery dosimetry in the 3-dimensional era: Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation. Practical Radiation Oncology 2013, 3: e55-60. PMID: 24674321, DOI: 10.1016/j.prro.2012.06.007.
- Halyard MY, Harris EE, Bailey L, Bellon JR, Freedman GM, Goyal S, Horst KC, Moran MS, Park CC, Suh WW, Toppmeyer D, Haffty BG. ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer. Oncology (Williston Park, N.Y.) 2014, 28: 157-64, C3. PMID: 24701707.
- Moran MS. Should triple-negative breast cancer (TNBC) subtype affect local-regional therapy decision making? American Society Of Clinical Oncology Educational Book / ASCO. American Society Of Clinical Oncology. Meeting 2014, e32-6. PMID: 24857120, DOI: 10.14694/EdBook_AM.2014.34.e32.
- Jones T, Neboori H, Wu H, Yang Q, Haffty BG, Evans S, Higgins S, Moran MS. Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer? Annals Of Surgical Oncology 2013, 20: 2866-72. PMID: 23661183, PMCID: PMC5731457, DOI: 10.1245/s10434-013-2994-6.
- Bai HX, Motwani SB, Higgins SA, Haffty BG, Wilson LD, Lannin DR, Evans SB, Moran MS. Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes? International Journal Of Clinical Oncology 2014, 19: 460-6. PMID: 23780727, DOI: 10.1007/s10147-013-0575-0.
- Khan AJ, Parikh RR, Neboori HJ, Goyal S, Haffty BG, Moran MS. The relative benefits of tamoxifen in older women with T1 early-stage breast cancer treated with breast-conserving surgery and radiation therapy. The Breast Journal 2013, 19: 490-5. PMID: 23800027, DOI: 10.1111/tbj.12150.
- Moran MS, Kaufman C, Burgin C, Swain S, Granville T, Winchester DP. What currently defines a breast center? Initial data from the national accreditation program for breast centers. Journal Of Oncology Practice / American Society Of Clinical Oncology 2013, 9: e62-70. PMID: 23814526, PMCID: PMC3595452, DOI: 10.1200/JOP.2012.000636.
- Hafeez F, Neboori HJ, Harigopal M, Wu H, Haffty BG, Yang Q, Schiff D, Moran MS. Is Ki-67 expression prognostic for local relapse in early-stage breast cancer patients treated with breast conservation therapy (BCT)? International Journal Of Radiation Oncology, Biology, Physics 2013, 87: 344-8. PMID: 23910708, DOI: 10.1016/j.ijrobp.2013.05.052.
- Moran MS, Goss D, Haffty BG, Kaufman CS, Winchester DP. Quality measures, standards, and accreditation for breast centers in the United States. International Journal Of Radiation Oncology, Biology, Physics 2010, 76: 1-4. PMID: 20005450, DOI: 10.1016/j.ijrobp.2009.08.010.
- Moran MS. Should low-risk patients be treated with three-dimensional conformal radiation therapy-accelerated partial-breast irradiation in an off-protocol setting? Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2013, 31: 4032-7. PMID: 24081936, DOI: 10.1200/JCO.2013.51.1642.
- Moran MS, Truong PT. Intraoperative accelerated partial breast irradiation: caution still warranted. International Journal Of Radiation Oncology, Biology, Physics 2014, 89: 496-8. PMID: 24929161, DOI: 10.1016/j.ijrobp.2014.01.034.
- Truong PT, Smith SL, Moran MS. Perspectives in breast cancer treatment: APBI and breast-conserving surgery. In reply to Morgan and Vaidya. International Journal Of Radiation Oncology, Biology, Physics 2014, 90: 967-8. PMID: 25585789, DOI: 10.1016/j.ijrobp.2014.07.047.
- Moran MS. Radiation therapy in the locoregional treatment of triple-negative breast cancer. The Lancet. Oncology 2015, 16: e113-22. PMID: 25752562, DOI: 10.1016/S1470-2045(14)71104-0.
- Yale Therapeutic RadiologySmilow Cancer Hospital Care Center - Waterford230 Waterford Parkway SouthWaterford, CT 06385